TMAM
CLVS

Tokio Marine Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Tokio Marine Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,988
Closed -$760K – 458
2017
Q1 		$760K Buy
+11,988
New +$729K 0.1% 172

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Tokio Marine Asset Management's CLVS Position: Q2 2017 in Review

Tokio Marine Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2017, closing a stake of 11,988 shares — an estimated $760K sold.

Tokio Marine Asset Management first reported a position in CLVS in Q1 2017 and held it in 1 quarter. The position peaked at $760K in Q1 2017. 271 funds tracked by Wall St. Rank hold CLVS as of Q2 2017.

  • Tokio Marine Asset Management reported no remaining Clovis Oncology, Inc. position as of Q2 2017 after selling out during the quarter.
  • Tokio Marine Asset Management sold 11,988 Clovis Oncology, Inc. shares in Q2 2017, an estimated $760K.
  • Tokio Marine Asset Management first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 1 quarter.
  • Tokio Marine Asset Management's Clovis Oncology, Inc. position peaked at $760K in Q1 2017.
  • 271 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2017.

Based on Tokio Marine Asset Management's 13F filing for Q2 2017, filed 27 Jul 2017.